Local epicardial robotic-enhanced hybrid ablation efficacy predictors for persistent atrial fibrillation

局部心外膜机器人辅助混合消融术治疗持续性房颤的疗效预测因素

阅读:2

Abstract

BACKGROUND: Hybrid ablation can manage persistent atrial fibrillation (PsAF) and long-standing persistent atrial fibrillation (LSPAF). Robotic-enhanced hybrid ablation (RE-HA) offers greater precision and stability. However, biophysical predictors of effective local epicardial radiofrequency ablation (ELRF) during epicardial ablation are unknown. OBJECTIVE: The purpose of this study was to compare the time course of biophysical predictors of ELRF and no-ELRF during the first stage of RE-HA in patients with PsAF and LSPAF. METHODS: We conducted a dual-center retrospective cohort study involving 92 consecutive patients with PsAF or LSPAF who underwent RE-HA between January 2021 and May 2024. Epicardial electrogram disappearance, defined as a reduction of bipolar voltages to <0.05 mV, baseline impedance (BI), and impedance drop (ID), were compared between ELRF and no-ELRF cases. Univariate and multivariate logistic regression models were used to identify predictive variables. Optimal cutoff values were determined using receiver operating characteristic curves. RESULTS: Among 2474 radiofrequency (RF) applications, significant predictors of ELRF included BI and ID at 1 and 8 seconds, with optimal cutoff values of <107, 0-7, and 5-17 Ω. The composite predictive model had an area under the receiver operating characteristic of 0.775, with 94% sensitivity, 53% specificity, and 65% accuracy. Our predictive ELRF score ranged from 0-4, and the Youden J test identifying a cutoff value of 3 as optimal. CONCLUSION: BI and progressive ID were strong predictors of local epicardial RE-HA efficacy. The composite model was a reliable tool for early identification of ELRF, potentially reducing RF delivery and enhancing procedural efficiency. Larger prospective studies are needed to validate these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。